Clinical Trial Update: Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes evaluating a five-drug combination (doxorubicin, vinblastine, dacarbazine, brentuximab vedotin, and nivolumab) in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab vedotin (Adcetris) (brentuximab vedotin)
• Dacarbazine (dacarbazine)
• Doxorubicin (doxorubicin)
• Vinblastine (vinblastine)
• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage IA Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING